arXiv AI
DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search
Read the original on arXiv AI →The Flow has not summarised this story yet — read it at arXiv AI.
Related stories
Hugging Face Trending Papers
Sep 28
M3OS: A Monte Carlo Graph Search-Orchestrated Multi-Agent LLM System for Evidence-Traced Molecular Optimization
M3OS is a multi‑agent large‑language‑model system that separates molecular‑design reasoning from optimization‑state management using a Monte Carlo graph search. The system maintains a persistent graph of evaluated candidates, transformations, and evidence, while LLM agents use role‑specific contexts to generate and edit molecules with tool‑driven and knowledge‑guided approaches. Across three benchmarks, M3OS outperforms baselines, demonstrating the benefit of persistent search state, specialized agents, and controlled execution for multi‑constraint molecular optimization.
arXiv Computation and Language
Sep 24
RexDrug: Reliable Multi-Drug Combination Extraction through Reasoning-Enhanced LLMs
arXiv:2603.08166v2 Announce Type: replace Abstract: Automated Drug Combination Extraction (DCE) from large-scale biomedical literature is crucial for advancing precision medicine and pharmacological...
arXiv AI
Sep 2
MMAI Gym for Science: Training Liquid Foundation Models for Drug Discovery
arXiv:2603.03517v2 Announce Type: replace-cross Abstract: General-purpose large language models (LLMs) that rely on in-context learning do not reliably deliver the scientific understanding and perfor...
arXiv AI
Sep 10
DrugReason: Dynamic Multi-View Reasoning over Knowledge Graph and Language Evidence for Drug Repurposing
arXiv:2609.06779v1 Announce Type: cross Abstract: Drug repurposing aims to identify new therapeutic uses for existing compounds and, compared with de novo drug discovery, offers a faster and more cos...
arXiv AI
Jul 10
DrugGen 2: A disease-aware language model for enhancing drug discovery
arXiv:2607. 08404v1 Announce Type: cross Abstract: Current computational approaches for drug design typically focus on generating molecules conditioned on specific targets or general molecular properties, often neglecting the influence of disease context on target behavior and therapeutic outcomes.
arXiv AI
1d ago
FRAGMENTA: Efficient End-to-end Fragmentation-based Generative Model with Agentic Tuning for Drug Lead Optimization in Small Data Regime
arXiv:2511.20510v3 Announce Type: replace Abstract: Molecule generation from extremely limited training data is a key challenge in drug discovery. Existing fragment-based methods are more suitable th...